# Sjogrens Syndrome Measured by Ultrasound

> **NCT03411850** · PHASE2 · UNKNOWN · sponsor: **Arthritis & Rheumatism Associates, P.C.** · enrollment: 20 (actual)

## Conditions studied

- Sjogren's Syndrome

## Interventions

- **BIOLOGICAL:** Orencia
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03411850
- **Lead sponsor:** Arthritis & Rheumatism Associates, P.C.
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-05
- **Primary completion:** 2021-05
- **Final completion:** 2021-12
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2021-05-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03411850

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03411850, "Sjogrens Syndrome Measured by Ultrasound". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03411850. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*